glp-1 agonist adverse effects Receptor Agonists side effects of glp-1 agonists

Consumers and physicians are increasingly favoring advanced therapies such as semaglutide (Wegovy) and tirzepatide (Zepbound) for their proven weight loss efficacy and cardiovascular benefits

Hospital pharmacies is anticipated to have the largest share of 36.3% of the market in 2026

Rebound or retention: a meta-analysis of weight regain after the discontinuation of glucagon-like peptide-1 (GLP-1) receptor agonists and other anti-obesity drugs

Weekly semaglutide also reduced the incidence cardiovascular events in overweight patients with pre-existing cardiovascular disease but without diabetes and also in obese patients without diabetes (24)

For example, supplementing with CLA can lead to side effects like gas and diarrhea, while garcinia cambogia supplements may cause liver damage in extreme cases

Meanwhile these agents have the potential to reduce major adverse cardiovascular events (MACE) in patient with T2DM as a drug class, individual drugs have different potency and effects they need tailored approach to align with patient treatment goals rather than generalized use (117)